Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery

Circulation Research
A W ClowesD Belin

Abstract

Although the level of plasminogen activator (PA) expression has been correlated with cellular proliferation and migration in vitro, this relation has not been established in tissue undergoing repair. In a rat model of arterial injury, we have measured the expression of PAs by vascular smooth muscle cells (SMCs) during entry into the growth cycle (0-24 hours) and subsequent migration from the media to the intima (starting at approximately 4 days). In normal rat carotid, low levels of urokinase-type PA (uPA) and tissue-type PA (tPA) are present; after removal of the endothelium, only uPA is detected in the media. uPA activity in extracts of carotid arteries increases and reaches a maximum between 16 and 24 hours after injury; uPA mRNA increases steadily and is maximal at 7 days. tPA activity appears at 3 days and is maximal at 7 days; tPA mRNA is present in normal vessels and reaches a maximum by 7 days. Most of the tPA in the media is associated with SMC and not with regenerating endothelium. Furthermore, tPA is present in the media before the SMCs migrate into the intima. These results demonstrate that PA expression by vascular SMCs is differentially regulated, with uPA present during mitogenesis and tPA during migration.

References

Oct 1, 1977·The Journal of Cell Biology·S T Rohrlich, D B Rifkin
Jul 1, 1978·The Journal of Experimental Medicine·A Granelli-Piperno, E Reich
Oct 1, 1978·Journal of Cellular Physiology·D J Loskutoff, D Paul
Jan 1, 1979·Thrombosis Research·E G Levin, D J Loskutoff
Jul 1, 1978·Medical Hypotheses·F H Sims
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J FingerleM A Reidy
Nov 25, 1987·Biochimica Et Biophysica Acta·K TryggvasonT Salo
Jan 1, 1985·Advances in Cancer Research·K DanøL Skriver
Apr 1, 1987·The Journal of Cell Biology·F BlasiK Danø
Apr 6, 1987·FEBS Letters·J D Vassalli, D Belin
Dec 1, 1987·The Journal of Clinical Investigation·K A HajjarR L Nachman
Jan 1, 1988·Annual Review of Cell Biology·O Saksela, D B Rifkin
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L JonassonG K Hansson
Oct 15, 1981·International Journal of Cancer. Journal International Du Cancer·R L O'GradyR W Stephens
Mar 12, 1984·FEBS Letters·P KristensenK Danø
Sep 1, 1982·The Journal of Cell Biology·E G Levin, D J Loskutoff
Oct 1, 1982·Experimental Cell Research·R R Schleef, C R Birdwell
Oct 1, 1981·Experimental and Molecular Pathology·G H GoldsmithA L Robertson

❮ Previous
Next ❯

Citations

Mar 20, 1998·Journal of Clinical Pharmacology·D C Celentano, W H Frishman
Nov 1, 1992·Cancer Metastasis Reviews·H C Kwaan
May 4, 1999·Biulleten' eksperimental'noĭ biologii i meditsiny·V V StepanovaV A Tkachuk
Jun 20, 2007·Histochemistry and Cell Biology·A K M Tarikuz ZamanBurton E Sobel
Aug 2, 1996·Atherosclerosis·E B Smith
May 5, 2005·The Journal of Surgical Research·Suzanne M NichollMark G Davies
Nov 15, 2002·The American Journal of Medicine·Burton E Sobel
Feb 1, 1997·The Annals of Thoracic Surgery·E Allaire, A W Clowes
Jan 14, 2003·Fertility and Sterility·Ujjwal Kumar Rout, Michael P Diamond
Sep 21, 2000·Atherosclerosis·M Y SalameD P deBono
Nov 5, 1997·Progress in Cardiovascular Diseases·P Libby, H Tanaka
Aug 26, 1998·Progress in Cardiovascular Diseases·W B BatchelorB H Strauss
May 16, 2002·Transplantation Proceedings·Agnieszka PerkowskaM Lao
Jun 29, 2001·Pathologie-biologie·M P JacobJ B Michel
Oct 1, 1997·Trends in Cardiovascular Medicine·V Ellis
Sep 17, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Chunming DongPascal J Goldschmidt-Clermont
Jun 2, 1998·Kidney International·P Carmeliet, D Collen
May 19, 1994·The New England Journal of Medicine·G H Gibbons, V J Dzau
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·V Lindner, M A Reidy
Dec 1, 1991·British Journal of Haematology·M F Scully
Oct 1, 1994·Journal of Internal Medicine·P CarmelietD Collen
Sep 1, 1996·Clinical and Experimental Pharmacology & Physiology·V TkachukA Bobik
Aug 10, 2010·American Journal of Respiratory Cell and Molecular Biology·Michael SchuligaAlastair G Stewart
Sep 1, 1991·The Journal of Clinical Investigation·M W MajeskyM A Reidy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.